Home › Funds › Commodore Capital LP › ANTX
Commodore Capital LP position in ANTX
AN2 THERAPEUTICS INC · Health Care
Commodore Capital LP reported holding 2,933,680 shares of ANTX (AN2 THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$14.2M, representing 0.85% of its reported portfolio and ranking #24 among its reported holdings. Commodore Capital LP has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Commodore Capital LP's ANTX position evolved
Commodore Capital LP first disclosed a stake in ANTX in Q1 2026 at 2,333,713 shares (US$8.0M). The position peaked in Q2 2026 at 2,933,680 shares, worth US$14.2M. Across 2 filings, Commodore Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,933,680 shares valued at US$14.2M — an increase of 599,967 shares quarter over quarter.. Notable position changes include a 26% increase in Q2 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.33M | $7.98M | New |
| Q2 2026 | 2.93M | $14.20M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANTX and 13F data
ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$15.3M), Spruce Street Capital LP (US$8.0M), Almitas Capital LLC (US$7.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANTX
- Vivo Capital, LLC 3.15M sh · $15.26M · Q2 2026
- Spruce Street Capital LP 1.66M sh · $8.04M · Q2 2026
- Almitas Capital LLC 1.47M sh · $7.11M · Q2 2026
- Boxer Capital Management, LLC 749.03K sh · $3.63M · Q2 2026
- Stonepine Capital Management, LLC 551.69K sh · $2.67M · Q2 2026
- Sio Capital Management, LLC 529.93K sh · $2.56M · Q2 2026
- Ally Bridge Group (NY) LLC 526.32K sh · $2.55M · Q2 2026
- Prosight Management, LP 474.64K sh · $2.30M · Q2 2026
- Aldebaran Capital, LLC 367.44K sh · $1.78M · Q2 2026
- Velan Capital Investment Management LP 40.00K sh · $193.60K · Q2 2026
More on Commodore Capital LP
FAQ
How long has Commodore Capital LP held ANTX?
Commodore Capital LP has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Commodore Capital LP's current position in ANTX?
As of Q2 2026, Commodore Capital LP holds 2.93M shares of ANTX (AN2 THERAPEUTICS INC), valued at $14.20M, representing 0.85% of its reported portfolio and ranking #24.
Has Commodore Capital LP been buying or selling ANTX?
In the latest 13F filing (Q2 2026), Commodore Capital LP increased its position in ANTX. The position peaked in Q2 2026 at 2.93M shares.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Spruce Street Capital LP, Almitas Capital LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.